XCF-91391-42974
3 vaccinations
2 coded responses
21 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 087 / NJ
- Registered
- 2021-08-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-10
Dose 1 — Pfizer-BioNTech
-
2021-08-11
Registered in v-safe
-
2021-08-11
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-08-12
- 2021-08-14
- 2021-08-15
- 2021-08-16
- 2021-08-17
-
2021-08-24
Survey response — day 14, dose 1MedDRA: Hypertension, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: High blood pressure · Healthcare visit (other): More frequent maternity visitsMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-24
Report sent to call center — day 14, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-25
-
2021-08-31
Dose 2 — Pfizer-BioNTech
- 2021-08-31
-
2021-09-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-09-02
-
2021-09-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-09-04
- 2021-09-05
-
2021-09-07
Health check-in — day 7, dose 2Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-09-16
Survey response — day 14, dose 2MedDRA: Gestational hypertension — Feeling: Fair · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Gestational hypertensionMedDRA releases: 2024-11 · check-in free text available
-
2021-09-16
Report sent to call center — day 14, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-17
-
2022-02-16
Dose 3 — Pfizer-BioNTech
- 2022-02-25
- 2022-03-02
- 2022-03-16
- 2022-03-23
- 2022-05-20
- 2022-08-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-10 | Pfizer-BioNTech | No |
| 2 | 2021-08-31 | Pfizer-BioNTech | No |
| 3 | 2022-02-16 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-08-24 | Unsuccessful | |
| 2021-09-16 | Unsuccessful |
Free text
Release 9 — day 14, dose 1
Release 9 — day 14, dose 2
Symptoms: Gestational hypertension
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | · | ✓ |
| SD | Gestational hypertension | · | · | ✓ |
| SD | Hypertension | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release